ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) Other Operating Expense : €-0.71 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) Other Operating Expense?

ImmuneOnco Biopharmaceuticals (Shanghai)'s Other Operating Expense for the six months ended in Dec. 2024 was €-0.62 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.71 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai)'s quarterly Other Operating Expense declined from Dec. 2023 (€0.81 Mil) to Jun. 2024 (€-0.08 Mil) and declined from Jun. 2024 (€-0.08 Mil) to Dec. 2024 (€-0.62 Mil).

ImmuneOnco Biopharmaceuticals (Shanghai)'s annual Other Operating Expense increased from Dec. 2022 (€1.70 Mil) to Dec. 2023 (€2.40 Mil) but then declined from Dec. 2023 (€2.40 Mil) to Dec. 2024 (€-0.71 Mil).

ImmuneOnco Biopharmaceuticals (Shanghai) Other Operating Expense Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) Other Operating Expense Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

-0.54

1.70

2.40

-0.71

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial			0.11	1.60	0.81	-0.08	-0.62

ImmuneOnco Biopharmaceuticals (Shanghai) Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.71 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai) Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

01541:Hong Kong

Address

1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN

Website

http://cn.immuneonco.com

ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines